Trial intelligence / Profile preview

Renal Perfusion and MAP After Liver Transplantation

NCT02455115Completed

Sponsor
Sahlgrenska University Hospital
Start
Jan 2015
Primary completion
Feb 2016
Countries
1
01

Overview

Randomised, open-label trial (3 arms), sponsored by Sahlgrenska University Hospital. Primary endpoint: Change in Glomerular filtration rate. Started Jan 2015; status: completed.

Beyond the preview

Go deeper on NCT02455115.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02455115.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call